TY  - GEN
AU  - Kissling, Esther
AU  - Pozo Sanchez, Francisco
AU  - Buda, Silke
AU  - Vilcu, Ana-Maria
AU  - Rizzo, Caterina
AU  - Gherasim, Alin Manuel
AU  - Horváth, Judit Krisztina
AU  - Brytting, Mia
AU  - Domegan, Lisa
AU  - Meijer, Adam
AU  - Paradowska-Stankiewicz, Iwona
AU  - Machado, Ausenda
AU  - Vučina, Vesna Višekruna
AU  - Lazar, Mihaela
AU  - Johansen, Kari
AU  - Dürrwald, Ralf
AU  - van der Werf, Sylvie
AU  - Bella, Antonino
AU  - Larrauri, Amparo
AU  - Ferenczi, Annamária
AU  - Zakikhany, Katherina
AU  - O'Donnell, Joan
AU  - Dijkstra, Frederika
AU  - Bogusz, Joanna
AU  - Guiomar, Raquel
AU  - Valenciano, Marta
AU  - Filipović, Sanja Kurečić
AU  - Pitigoi, Daniela
AU  - Penttinen, Pasi
AU  - I-MOVE/I-MOVE+ study team
AU  - Mazagatos, Clara
AU  - Casas Flecha, Inmaculada
PY  - 2019
DO  - 10.1016/j.jvacx.2019.100042
UR  - http://hdl.handle.net/20.500.12105/11617
AB  - Influenza A(H3N2) viruses predominated in Europe in 2016-17. In 2017-18 A(H3N2) and A(H1N1)pdm09 viruses co-circulated. The A(H3N2) vaccine component was the same in both seasons; while the A(H1N1)pdm09 component changed in 2017-18. In both seasons,...
LA  - eng
PB  - Elsevier
KW  - Case-control study
KW  - Europe
KW  - Influenza
KW  - Influenza vaccine
TI  - Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)
TY  - research article
ER  -